High drug prices can create significant barriers to access for patients. Even in countries with robust healthcare systems, the out-of-pocket costs can be prohibitive, leading some patients to forgo necessary treatments. In the United States, for example, high co-payments and deductibles can limit access, particularly for those without comprehensive insurance coverage.
The financial burden of cancer drugs can lead to what is known as "financial toxicity," where patients experience stress and hardship due to the cost of their treatment. This can affect their overall well-being and even their adherence to prescribed therapies.
